Proteome Sciences plc (LON:PRM – Get Free Report)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 2.28 and traded as low as GBX 1.66. Proteome Sciences shares last traded at GBX 1.79, with a volume of 4,477 shares trading hands.
Proteome Sciences Stock Performance
The company has a market capitalization of £6.28 million, a PE ratio of -1.58 and a beta of 0.07. The stock’s fifty day simple moving average is GBX 2.25 and its 200-day simple moving average is GBX 2.28. The company has a debt-to-equity ratio of -179.32, a quick ratio of 0.37 and a current ratio of 0.11.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Articles
- Five stocks we like better than Proteome Sciences
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
